Dr. David Freidberg

Dr. David Freidberg
Dr. David Freidberg received his medical degree from the University of Texas Medical Branch, Galveston, and completed his Urology Residency at the University of New Mexico, Albuquerque. Dr. Freidberg sees both male and female patients, and has special interests in general urology, prostate cancer, kidney cancer, bladder cancer, Benign Prostatic Hyperplasia (BPH or enlarged prostate), urinary incontinence, hypoandrogenism, urinary tract infections, kidney stones, performing vasectomies and the management of advanced prostate cancer. Dr. Freidberg is now offering Aquablation for men with BPH. This FDA approved procedure uses unheated, sterile saline to precisely remove prostate tissue overgrowth. Dr. Freidberg serves as part of Urology Austin’s Advanced Prostate Cancer Care Team along with his colleagues Dr. Richard Garza, Dr. Eric Giesler and Dr. David Phillips. This team manages patients with prostate cancer recurrence after initial local therapy such as robotic prostatectomy or radiation. Care approaches include newer medical oncolytics (Xtandi, Zytiga, Erleada, Nubeqa and Yonsa) and immunotherapies (Provenge).

Languages Spoken:


Medical School:

University of Texas Medical Branch, Galveston


University of New Mexico, Albuquerque

All surgical treatments have inherent and associated side effects. Individual’s outcomes may depend on a number of factors, including but not limited to patient characteristics, disease characteristics and/or surgeon experience. The most common side effects are mild and transient and may include mild pain or difficulty when urinating, discomfort in the pelvis, blood in the urine, inability to empty the bladder or a frequent and/or urgent need to urinate, and bladder or urinary tract infection. Other risks include ejaculatory dysfunction and a low risk of injury to the urethra or rectum where the devices gain access to the body for treatment. Further, there may be other risks as in other urological surgery, such as anesthesia risk or the risk of infection, including the potential transmission of blood borne pathogens. For more information about potential side effects and risks associated with Aquablation therapy for Benign Prostatic Hyperplasia (BPH) treatment, speak with your urologist or surgeon. Prior to using our products, please review the Instructions for Use, Operator’s Manual or User Manual, as applicable, and any accompanying documentation for a complete listing of indications, contraindications, warnings, precautions and potential adverse events. No claim is made that the AquaBeam Robotic System will cure any medical condition, or entirely eliminate the diseased entity. Repeated treatment or alternative therapies may sometimes be required.

Rx Only